Companion animal vaccines market report gives a comprehensive outlook on companion animal vaccines across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on companion animal vaccines market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, disease type, vaccine type, distribution channel, and geographic regions. This report studies companion animal vaccines market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the companion animal vaccines market report includes animal demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. A sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-companion-animal-vaccines-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
Global companion animal vaccines market estimated to be valued US$ 2406 Mn in 2017 and poised to grow at CAGR of 7.8% over 2017-2023. The market for companion animal vaccines projected to reach US$ 3767 Mn by 2023 owing to rising human and companion animals bondage by means of adoption across the globe.
There has been a rise in awareness regarding pet health among pet owners across the developed and developing economies expected to drive market revenue growth over the forecast period. Moreover, several studies on human and companion animals’ interactions showed that association with companion animals results in positive health benefits.
Several respondents and pet owners revealed that pet expenditure is increasingly becoming an integral part of their monthly expenditure and companion animals are part of several families across the developed and developing economies.
North America market leads the global companion animal health vaccines and projected to remain same over the forecast period owing to large pet ownership. According to data from American Pet Products association as of 2016, around 40% of households owned one or the other pet animals. Europe companion animal vaccines market holds significant share in global companion animal vaccines market. Increased product introduction in Europe vaccine against Leishmania infantum, the causal agent of canine leishmaniosis which is significant breakthrough against zoonotic disease is one of the factors driving the market positively.
To view TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-companion-animal-vaccines-market/#ulp-c654SbFYO64MsOhu[/URL]
Competition Assessment
Key players profiled in the global companion animal vaccines market include:
• Bayer AG (Germany)
• Boehringer Ingelheim GmbH (Germany)
• Ceva Santé Animale (France)
• Eli Lilly and Company (U.S)
• Heska Co. (U.S)
• Hester biosciences (India)
• Merck & Co., Inc. (U.S)
• Vétoquinol S.A. (France)
• Virbac S.A. (France)
• Zoetis Inc. (U.S)
Need more information about this report @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-companion-animal-vaccines-market/[/URL]
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553